640 filings
Page 25 of 32
8-K
tmxlo
20 Jul 10
ZIOPHARM Announces Initiation of Palifosfamide Pivotal Study
12:00am
S-8
i93 dxzttkh
1 Jul 10
Registration of securities for employees
12:00am
8-K
7zbbiv23rs5jj
23 Jun 10
Submission of Matters to a Vote of Security Holders
12:00am
8-K
zyjhg rdfph37oi9gxil
21 Jun 10
Other Events
12:00am
8-K
nkg6 rn89hy
7 Jun 10
ZIOPHARM Presents Positive Palifosfamide PICASSO
12:00am
8-K
njhf whrxeu3bm
2 Jun 10
ZIOPHARM announces proposed public offering of common stock
12:00am
424B5
hnf58zuq1 x8ycl
27 May 10
Prospectus supplement for primary offering
12:00am
FWP
3oeqk3jwuvo9 8h
27 May 10
Free writing prospectus
12:00am
424B5
6svxp4 rap
26 May 10
Prospectus supplement for primary offering
12:00am
8-K
t05kup7ehi7v2
21 May 10
ZIOPHARM to Present Further Palifosfamide PICASSO Phase II Results
12:00am
EFFECT
jq4 q94yo5dfy4t
13 May 10
Notice of effectiveness
12:00am
CORRESP
xcd006ght4dkbkwj5
11 May 10
Correspondence with SEC
12:00am
UPLOAD
6vh8ud jndsqylwkiz
7 May 10
Letter from SEC
12:00am
CORRESP
p3qs72bu9w2xz0a
30 Apr 10
Correspondence with SEC
12:00am
10-K/A
y2d5s
30 Apr 10
Annual report (amended)
12:00am
8-K
7v37d5 6ohrdvnann3l
30 Apr 10
Ziopharm Reports First Quarter Financial Results
12:00am